BMN 111-211 A Phase 2, Randomized, Human Growth Hormone-Controlled, Multicenter, Basket Study of Vosoritide in Children with Turner Syndrome, Short Stature Homeobox-Containing Gene Deficiency, and Noonan Syndrome with an Inadequate Response to Human Growt

Grants and Contracts Details

StatusActive
Effective start/end date11/21/2411/21/26

Funding

  • BioMarin Pharma Inc: $2.00